HighVista Strategies’s Pharvaris PHVS Stock Holding History

HighVista Strategies’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.76M	Sell	97,866 -64,504	-40%	-$1.72M	0.76%	45
2025 Q4	$4.51M	Buy	+162,370	New	+$3.91M	1.16%	27
2025 Q3	–	Sell	-23,739	Closed	-$418K	–	168
2025 Q2	$418K	Buy	23,739 +971	+4%	+$15.6K	0.15%	134
2025 Q1	$357K	Hold	22,768	–	–	0.14%	134
2024 Q4	$436K	Hold	22,768	–	–	0.16%	126
2024 Q3	$422K	Buy	22,768 +6,018	+36%	+$110K	0.15%	137
2024 Q2	$315K	Hold	16,750	–	–	0.12%	134
2024 Q1	$387K	Buy	+16,750	New	+$445K	0.14%	127

Other funds holding PHVS

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $1.02B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

HighVista Strategies's PHVS Position: Q1 2026 in Review

HighVista Strategies reduced its Pharvaris (PHVS) stake by 40% in Q1 2026, selling an estimated $1.72M and leaving 97,866 shares worth $2.76M. The position accounts for 0.76% of the portfolio, ranked #45.

HighVista Strategies first reported a position in PHVS in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.51M in Q4 2025. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

HighVista Strategies held 97,866 shares of Pharvaris worth $2.76M as of Q1 2026.
HighVista Strategies sold 64,504 Pharvaris shares in Q1 2026, an estimated $1.72M.
Pharvaris made up 0.76% of HighVista Strategies's portfolio in Q1 2026, its #45 holding.
HighVista Strategies first reported a position in Pharvaris in Q1 2024 and has held it in 8 quarters since.
HighVista Strategies's Pharvaris position peaked at $4.51M in Q4 2025.
110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.